日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial

托瑞普利单抗联合化疗作为广泛期小细胞肺癌的一线治疗:EXTENTORCH III期随机临床试验

Cheng, Ying; Zhang, Wei; Wu, Lin; Zhou, Caicun; Wang, Donglin; Xia, Bing; Bi, Minghong; Fu, Xiuhua; Li, Chong; Lv, Dongqing; Zhao, Yanqiu; Chen, Gongyan; Yi, Tienan; Huang, Jianan; Li, Min; Yang, Runxiang; Huang, Xiaoping; Wang, Ye; Zhang, Mingjun; Pan, Yueyin; Sun, Yilan; Hu, Sheng; Zhang, Xiqin; Zhou, Min; Fang, Jian; Jin, Faguang; Liu, Yunpeng; Li, Yinyin; Zhang, Zhihong; Hu, Jie; Liu, Laiyu; Wang, Rui; Li, Yan; Gu, Kangsheng; Ding, Cuimin; Fan, Qingxia; Zhang, Guojun; Chen, Yongxing; Jiang, Liyan; Zheng, Wei-E; Chen, Shaoshui; Huang, Cheng; Han, Zhigang; Yang, Hong; Wang, Jianfang; Wang, Baocheng; Wu, Huita; Bao, Yongxing; Li, Manxiang; Luo, Xianming; Gu, Shanshan; Yu, Wenbo; Xu, Kai; Zhang, Simo; Yu, Jianjun

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)

奥莫替尼与吉非替尼治疗未经治疗的 EGFR 突变晚期非小细胞肺癌患者的中枢神经系统疗效:一项随机 III 期试验 (AENEAS) 的数据

Lu, Shun; Dong, Xiaorong; Jian, Hong; Chen, Jianhua; Chen, Gongyan; Sun, Yuping; Ji, Yinghua; Wang, Ziping; Shi, Jianhua; Lu, Junguo; Chen, Shaoshui; Lv, Dongqing; Zhang, Guojun; Liu, Chunling; Li, Juan; Yu, Xinmin; Lin, Zhong; Yu, Zhuang; Wang, Zhehai; Cui, Jiuwei; Xu, Xingxiang; Fang, Jian; Feng, Jifeng; Xu, Zhi; Ma, Rui; Hu, Jie; Yang, Nong; Zhou, Xiangdong; Wu, Xiaohong; Hu, Chengping; Zhang, Zhihong; Lu, You; Hu, Yanping; Jiang, Liyan; Wang, Qiming; Guo, Renhua; Zhou, Jianying; Li, Baolan; Hu, Chunhong; Tong, Wancheng; Zhang, Helong; Ma, Lin; Chen, Yuan; Jie, Zhijun; Yao, Yu; Zhang, Longzhen; Weng, Jie; Li, Weidong; Xiong, Jianping; Ye, Xianwei; Duan, Jianchun; Yang, Haihua; Sun, Meili; Wei, Hongying; Wei, Jiawei; Zhang, Zheyu; Wu, Qiong

Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial

局部晚期胸段食管鳞状细胞癌同步放化疗:一项随机、多中心、III期临床试验,采用不同放射剂量和不同照射野。

Zhang, Jian; Li, Minghao; Zhang, Kaixian; Zheng, Anping; Li, Guang; Huang, Wei; Chen, Shaoshui; Chen, Xiangming; Li, Xiaomin; Sheng, Yanxing; Sun, Xinchen; Liu, Liping; Liu, Xiaowei; Li, Jie; Wang, Jun; Ge, Hong; Ye, Shucheng; Pang, Qingsong; Zhang, Xianwen; Dai, Shengbin; Yu, Richard; Gu, Wendong; Dai, Mingming; Siqin, Gaowa; Han, Yunwei; Ge, Xiaolin; Yuan, Xin; Yang, Yongjing; Zhu, Haiwen; Pu, Juan; Dong, Lihua; Sun, Xiangdong; Zhou, Jundong; Mao, Weidong; Gao, Fei; Lin, Haiqun; Gong, Heyi; Zhou, Tao; Li, Zhenjiang; Li, Hongsheng; Wang, Zhongtang; Li, Baosheng

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations

AENEAS:一项随机III期试验,比较奥莫替尼与吉非替尼作为一线疗法治疗伴有EGFR 19号外显子缺失或L858R突变的局部晚期或转移性非小细胞肺癌的疗效

Lu, Shun; Dong, Xiaorong; Jian, Hong; Chen, Jianhua; Chen, Gongyan; Sun, Yuping; Ji, Yinghua; Wang, Ziping; Shi, Jianhua; Lu, Junguo; Chen, Shaoshui; Lv, Dongqing; Zhang, Guojun; Liu, Chunling; Li, Juan; Yu, Xinmin; Lin, Zhong; Yu, Zhuang; Wang, Zhehai; Cui, Jiuwei; Xu, Xingxiang; Fang, Jian; Feng, Jifeng; Xu, Zhi; Ma, Rui; Hu, Jie; Yang, Nong; Zhou, Xiangdong; Wu, Xiaohong; Hu, Chengping; Zhang, Zhihong; Lu, You; Hu, Yanping; Jiang, Liyan; Wang, Qiming; Guo, Renhua; Zhou, Jianying; Li, Baolan; Hu, Chunhong; Tong, Wancheng; Zhang, Helong; Ma, Lin; Chen, Yuan; Jie, Zhijun; Yao, Yu; Zhang, Longzhen; Jie, Weng; Li, Weidong; Xiong, Jianping; Ye, Xianwei; Duan, Jianchun; Yang, Haihua; Sun, Meili; Sun, Changan; Wei, Hongying; Li, Chuan; Ali, Siraj M; Miller, Vincent A; Wu, Qiong

miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer

miR-3196作为肿瘤抑制因子,可预测胃癌患者的生存预后

Chen, Guo; Wan, Jinliang; Wang, Zhenbo; Li, Lei; Jia, Hongying; Xing, Shaozhi; Chen, Shaoshui; Fan, Xiaocheng; Li, Rui

Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma

动态增强磁共振成像(DCE-MRI)和弥散加权成像(DWI)联合预测食管癌同步放化疗的疗效

Liu, Changmin; Sun, Roger; Wang, Jing; Ning, Fangling; Wang, Zhenbo; Luo, Judong; Chen, Shaoshui; Yuan, Shuanghu

Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial

福沙匹坦与阿瑞匹坦在预防接受顺铂类化疗患者化疗引起的恶心呕吐方面的疗效比较:一项多中心、随机、双盲、双模拟、阳性对照的III期临床试验

Zhang, Zhonghan; Yang, Yunpeng; Lu, Ping; Li, Xiaoqin; Chang, Jianhua; Zheng, Rongsheng; Zhou, Lei; Chen, Shaoshui; Chen, Xiaopin; Ren, Biyong; Gu, Wei; Jiang, Xiaodong; Peng, Jiyong; Huang, Miaolong; Feng, Guosheng; Shen, Peng; Zhang, Qingyuan; Zhang, Baihong; Huang, Yan; He, Jingdong; Chen, Yinglan; Cao, Jingxu; Wang, Hong; Li, Wei; Wan, Huiping; Nan, Kejun; Liao, Zijun; Zhang, Cuiying; Lin, Zhong; Zhong, Diansheng; Xu, Qing; Liu, Hailong; Sun, Tao; Deng, Yanming; Zhang, Li

Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer

miR-939-3p 过表达预示肺癌预后不良并促进疾病进展

Han, Xia; Du, Chunjuan; Chen, Yinghai; Zhong, Xiaofei; Wang, Feng; Wang, Juan; Liu, Changmin; Li, Mianli; Chen, Shaoshui; Li, Baosheng